| Financial Year |
March 31 2023 |
| Monetary Funds |
82,186,749.89 |
| Held-for-trading Financial Assets |
1,008,523.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
995,008,626.35 |
| Advances to Suppliers |
60,699,451.72 |
| Other Receivables |
4,097,330.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
289,098,319.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,799,194.23 |
| Total Current Assets |
1,681,223,462.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,900,272.13 |
| Fixed Assetes |
749,895,863.35 |
| Under-construction Projects |
6,271,938.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,795,269.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,158,990.24 |
| Deferred Income Tax Assets |
60,932,222.01 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,074,139,789.57 |
| Total Assets |
2,755,363,252.54 |
| Short-Term Loans |
631,709,666.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
87,255,053.64 |
| Accounts Payable |
208,667,881.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,659,781.63 |
| Taxes Payable |
24,084,963.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,230,968.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
186,679,858.90 |
| Other Current Liabilities |
2,280,069.20 |
| Sub-Total of Current Liabilities |
1,213,585,365.55 |
| Long-term Loans |
69,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
219,401,119.05 |
| Total Liabilities |
1,432,986,484.60 |
| Paid-In Capital(Or Share Stock) |
1,208,455,224.00 |
| Capital Surplus |
182,915,648.60 |
| Surplus Reserve |
6,720,128.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-84,423,482.90 |
| Minority Stockholder's Interest |
58,046,314.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,264,330,453.42 |
| Owner's Equity（Stockholder's Equity） |
1,322,376,767.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,755,363,252.54 |
